ArticleJournal of dental sciences2026
Human oral microbiota dysbiosis may be a novel non-invasive indicator of erectile dysfunction.
Article in Journal of dental sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/purpose: Dysbiosis of the oral microbiota has been associated with various human diseases, however, the relationship between the oral microbiota and erectile dysfunction (ED) remains unexplored. This study aimed to investigate the connection between the oral microbiota and ED, ultimately identifying a novel non-invasive indicator for ED. Materials and methods: We recruited 74 male patients diagnosed with erectile dysfunction and 38 men with normal sexual function to serve as the control group. We compared the overall conditions and clinical data between the two groups. Oral samples were collected from the subjects, followed by 16S rRNA sequencing. We assessed the differences in oral microbiota between the two groups. We analyzed the correlation between oral microbiota and clinical indicators, ultimately constructing ten machine learning prediction models based on the oral microbiota data. Results: There were distinct differences in the oral microbiota at both the phylum and genus levels between the two groups. Furthermore, significant differences in both α-diversity and β-diversity were observed between the two groups. The different oral microbiota between the groups were correlated with certain clinical indicators. We constructed ten machine learning prediction models, among which the Light Gradient Boosting Machine (LGBM) model demonstrated superior performance, achieving a relatively higher area under the curve (0.711), accuracy (0.733), sensitivity (0.784), specificity (0.636) and F1-score (0.795). Conclusion: An dysbiosis in oral microbiota may have a potential connection to ED. This dysbiosis could serve as an indicator for assessing the risks associated with the occurrence and progression of ED.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.